Wockhardt gets DGCI approval for 2 new antibiotics

"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and skin structure infections including diabetic foot infections and concurrent bacteraemia...," the drug firm said. The new drug will target superbug like Methicillin resistant Staphylococcus aureus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2uLt0EH
via IFTTT